Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

被引：0
|
作者：
Amanda Hansson-Hedblom
Isabelle Axelsson
Lena Jacobson
Joakim Tedroff
Fredrik Borgström
机构：
[1] Quantify Research AB,
[2] Allergan Norden AB,undefined
[3] Neuroenheten Utsikten,undefined
来源：
The Journal of Headache and Pain | 2020年 / 21卷
关键词：
Migraine; Headache; onabotulinumtoxinA; Botox; Cost-effectiveness; Cost of illness; Burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden
    Ekman, M.
    Bienfait-Beuzon, C.
    Jackson, J.
    JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (12) : 845 - 855
  • [32] Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden
    M Ekman
    C Bienfait-Beuzon
    J Jackson
    Journal of Human Hypertension, 2008, 22 : 845 - 855
  • [33] Cost-effectiveness of influenza vaccination of elderly in Sweden
    Wolff, Ellen
    Larsson, S.
    Roth, A.
    Bastami, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 : 28 - 28
  • [34] Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
    Knight, Christopher
    Mauskopf, Josephine
    Ekelund, Mats
    Singh, Amitabh
    Yang, Shiyi
    Boggs, Robert
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (02): : 145 - 156
  • [35] Cost-effectiveness of simple insulin infusion: Sweden
    Henriksen, O.
    Dall, M.
    Warner, J.
    Parkin, C.
    DIABETOLOGIA, 2015, 58 : S483 - S483
  • [36] Cost-effectiveness of pneumococcal vaccination for elderly in Sweden
    Wolff, Ellen
    Storsaeter, Jann
    Ortqvist, Ake
    Naucler, Pontus
    Larsson, Sofie
    Lepp, Tiia
    Roth, Adam
    VACCINE, 2020, 38 (32) : 4988 - 4995
  • [37] The cost-effectiveness of oral triptan therapy in Sweden
    Ramsberg, J.
    Henriksson, M.
    CEPHALALGIA, 2007, 27 (01) : 54 - 62
  • [38] COST-EFFECTIVENESS OF COMPLYING WITH TREATMENT GUIDELINES IN SWEDEN
    Jonsson, E.
    Hansson-Hedblom, A.
    Ljunggren, O.
    Akesson, K.
    Spangeus, A.
    Borgstrom, F.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S440 - S440
  • [39] COST-EFFECTIVENESS OF ERENUMAB FOR THE PREVENTION OF MIGRAINE IN PORTUGAL
    Silva, C.
    Monge, S.
    Cooney, P.
    Mahon, R.
    Laires, P. A.
    VALUE IN HEALTH, 2020, 23 : S633 - S633
  • [40] Cost-effectiveness of antiepileptic drugs in migraine prophylaxis
    Adelman, JU
    Adelman, LC
    Von Seggern, R
    HEADACHE, 2002, 42 (10): : 978 - 983
12345